Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Implementation framework for AI deployment at scale in healthcare systems

Adnan HS. et al, (2025), Iscience, 28

Dysregulated immune proteins in plasma in the UK Biobank predict Multiple Myeloma 12 years before clinical diagnosis.

Fieggen J. et al, (2025), Blood adv

Navigating severe class imbalance in population cohort data

Fieggen J. et al, (2025)

Bridging the generalisation gap: synthetic data generation for multi-site clinical model validation

Segal B. et al, (2025)

Individualised treatment effects estimation with composite treatments and composite outcomes

Kumar Chauhan V. et al, (2025)

Application of large language models in medicine

Liu F. et al, (2025), Nature reviews bioengineering

Individualised Treatment Effects Estimation with Composite Treatments and Composite Outcomes

Chauhan VK. et al, (2025)

Dysregulated Immune Proteins in Plasma in the UK Biobank Predict Multiple Myeloma 12 years Before Clinical Diagnosis

Fieggen J. et al, (2025)

Aligning, autoencoding and prompting large language models for novel disease reporting

Liu F. et al, (2025), Ieee transactions on pattern analysis and machine intelligence

Exploring the effectiveness of instruction tuning in biomedical language processing

Rohanian O. et al, (2024), Artificial intelligence in medicine, 158

At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods.

Mesinovic M. et al, (2024), Sci rep, 14

Mitigating machine learning bias between high income and low-middle income countries for enhanced model fairness and generalizability.

Yang J. et al, (2024), Sci rep, 14

Data from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Data from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Figure 1 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Figure 1 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Figure 2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Figure 2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Figure 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Figure 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Load More

1
2
3
4
5
6
7

Include forthcoming?